// App-Quantinova.ai

248 : Metformin sensitizes endometrial cancer cells to chemotherapy by inhibiting IDH1-TET1 pathway

Researchers

Presenter

  • Mingzhu Bai

Principal Investigators

  • Zhenbo Zhang

  • Yinhua Yu

  • Youji Feng

Medical Centers

  • Shanghai Renji Hospital, Shanghai, China

  • Cancer Hospital Affiliated to Fudan University, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Paclitaxel

  • Progestin

  • CycloGest

  • Metformin Hydrochloride

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved